Moderna Inc (NASDAQ:MRNA)
| 127.33 BATS BZX Real-Time Price As of 1:40pm ET |  +1.12 / +0.89%Today’s Change | 115.03 Today|||52-Week Range 217.25 | -29.11% Year-to-Date |
Latest MRNA News | Press Releases
Today’s Trading
| Previous close | 126.21 |
| Today’s open | 126.53 |
| Day’s range | 124.26 - 128.36 |
| Volume | 82,788 |
| Average volume (3 months) | 3,519,157 |
| Market cap | $48.1B |
Data as of 1:40pm ET, 05/30/2023
Growth & Valuation
| Earnings growth (last year) | -29.90% |
| Earnings growth (this year) | -110.61% |
| Earnings growth (next 5 years) | -51.00% |
| Revenue growth (last year) | +3.78% |
| P/E ratio | 10.9 |
| Price/Sales | 3.91 |
| Price/Book | 2.54 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BIIBBiogen | -1.35 | -0.45% |
| ILMNIllumina Inc | -1.54 | -0.79% |
| ---- | ||
| BMRNBiomarin Pharmaceuti... | -1.61 | -1.82% |
Data as of 1:40pm ET, 05/30/2023
Financials
| Next reporting date | August 9, 2023 |
| EPS forecast (this quarter) | -$3.97 |
| Annual revenue (last year) | $19.1B |
| Annual profit (last year) | $8.4B |
| Net profit margin | 43.76% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
